Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

SELL
$40.65 - $59.54 $113,698 - $166,533
-2,797 Reduced 16.57%
14,078 $661,000
Q1 2023

May 08, 2023

SELL
$37.27 - $46.57 $596 - $745
-16 Reduced 0.09%
16,875 $708,000
Q4 2022

Feb 14, 2023

SELL
$32.2 - $43.61 $2,093 - $2,834
-65 Reduced 0.38%
16,891 $644,000
Q3 2022

Nov 10, 2022

SELL
$32.28 - $43.27 $172,504 - $231,234
-5,344 Reduced 23.96%
16,956 $664,000
Q2 2022

Aug 12, 2022

SELL
$27.52 - $37.99 $159,616 - $220,342
-5,800 Reduced 20.64%
22,300 $720,000
Q4 2021

Feb 14, 2022

SELL
$37.06 - $47.11 $103,768 - $131,908
-2,800 Reduced 9.06%
28,100 $1.2 Million
Q3 2021

Nov 08, 2021

SELL
$40.26 - $57.37 $64,416 - $91,792
-1,600 Reduced 4.92%
30,900 $1.37 Million
Q2 2021

Aug 09, 2021

BUY
$54.88 - $79.29 $1.78 Million - $2.58 Million
32,500 New
32,500 $1.85 Million
Q2 2018

Aug 10, 2018

SELL
$140.36 - $175.76 $735,486 - $920,982
-5,240 Closed
0 $0
Q1 2018

May 08, 2018

BUY
$152.15 - $192.33 $15,215 - $19,233
100 Added 1.95%
5,240 $845,000
Q4 2017

Feb 13, 2018

BUY
$60.72 - $167.34 $312,100 - $860,127
5,140
5,140 $846,000

Others Institutions Holding SAGE

About Sage Therapeutics, Inc.


  • Ticker SAGE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,422,300
  • Market Cap $323M
  • Description
  • Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...
More about SAGE
Track This Portfolio

Track Clari Vest Asset Management LLC Portfolio

Follow Clari Vest Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clari Vest Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clari Vest Asset Management LLC with notifications on news.